6-methyl-2-oxo-heptanoic acid | 76390-95-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 酮酸及其衍生物
• 英文名称: 6-methyl-2-oxo-heptanoic acid
• 英文别名: 6-Methyl-2-oxo-heptansaeure；6-Methyl-2-oxoheptanoic acid
• CAS: 76390-95-9
• 化学式: C₈H₁₄O₃
• 分子量: 158.197
• InChiKey: UKFYEQPRZKSNON-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  11
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  54.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  6-methyl-2-oxo-heptanoic acid 在 乙醚 作用下， 生成 (+)-2-Hydroxy-2-ethyl-6-methyl-heptansaeure-(1)
  参考文献：
  名称：

  Prelog; Watanabe, Justus Liebigs Annalen der Chemie, 1957, vol. 603, p. 1,5

  摘要：

  DOI：
• 作为产物：
  描述：

  Ethyl 6-methyl-2-oxoheptanoate 、 盐酸 以70%的产率得到
  参考文献：
  名称：

  LI, SHAO-BAI;CUI, YU-XIN;LI, YU-LIN;PAN, XIN-FU;WANG, YONG-KENG;HUANG, WE+, ACTA CHIM. SIN., 45,(1987) N 7, 687-691

  摘要：

  DOI：

文献信息

• Aminoacid derivatives as antihypertensives
  申请人：Merck & Co., Inc.

  公开号：US04374829A1

  公开（公告）日：1983-02-22

  The invention relates to new carboxyalkyl dipeptide derivatives and related compounds which are useful as antihypertensives.

  这项发明涉及新的羧基烷基二肽衍生物和相关化合物，可用作降压药。
• Substances and Pharmaceutical Compositions for the Inhibition of Glyoxalases and Their Use As Anti-Fungal Agents
  申请人：Huse Klaus

  公开号：US20080300303A1

  公开（公告）日：2008-12-04

  The present invention pertains to substances of the formula (I) wherein X is O or S; and R1-R4 are defined in the claims as inhibitors of glyoxalase I and/or II, pharmaceutical compositions comprising one or more compounds according to formula (I) and the use of one or more compounds according to formula (I) for the treatment of diseases associated with increased glycolytic metabolism. In one embodiment, the disease is a fungal infection.

  本发明涉及式（I）的物质，其中X是O或S; R1-R4在权利要求中定义为乙醛酸酯酶I和/或II的抑制剂，包含一个或多个式（I）化合物的制药组合物以及使用一个或多个式（I）化合物治疗与增加的糖酵解代谢相关的疾病。在一种实施方式中，该疾病是真菌感染。
• [EN] BIOLOGICAL FERMENTATION USING DIHYDROXYACETONE AS A SOURCE OF CARBON<br/>[FR] FERMENTATION BIOLOGIQUE UTILISANT DE LA DIHYDROXYACÉTONE COMME SOURCE DE CARBONE
  申请人：KEMBIOTIX LLC

  公开号：WO2017139420A1

  公开（公告）日：2017-08-17

  The present invention relates to the use of hydrocarbons derived from natural gas in the fermentative production of biochemicals including biofuels. More specifically, the present invention provides the method for manufacturing dihydroxyacetone ("DHA") from natural gas, biogas, biomass and CO2 released from industrial plants including electricity-generating plants, steel mills and cement factories and the use of DHA as a source of organic carbon in the fermentative production of biochemicals including biofuels. The present invention comprises three stages. In the first stage of the present invention, syngas and formaldehyde are produced from natural gas, biogas, biomass and CO2 released from industrial plants. In the second stage of the present invention, formaldehyde and syngas are condensed to produce DHA. In the third stage of the present invention, biochemicals including biofuels are produced from DHA using fermentation process involving wild type or genetically modified microbial biocatalysts.

  本发明涉及使用从天然气中提取的碳氢化合物在生物化学品，包括生物燃料的发酵生产中的应用。更具体地说，本发明提供了一种从天然气、沼气、生物质和工业厂房中释放的CO2中制造二羟基丙酮（"DHA"）的方法，以及将DHA作为有机碳源在发酵生产中制造生物化学品，包括生物燃料的应用。本发明包括三个阶段。在本发明的第一阶段中，从天然气、沼气、生物质和工业厂房中释放的CO2中产生合成气和甲醛。在本发明的第二阶段中，甲醛和合成气被凝结成DHA。在本发明的第三阶段中，使用野生型或基因改造的微生物生物催化剂进行发酵过程，从DHA中生产生物化学品，包括生物燃料。
• Amino acid derivatives as antihypertensives
  申请人：Merck & Co., Inc.

  公开号：US04472380A1

  公开（公告）日：1984-09-18

  There are disclosed processes for preparing carboxyalkyl dipeptide derivatives and related compounds which are useful as angiotension converting enzyme (ACE) inhibitors and as antihypertensives and pharmaceutical compositions containing these carboxyalkyl dipeptide compounds in combination with another antihypertensive and/or diuretic compound.

  本发明公开了制备羧基烷基二肽衍生物及其相关化合物的方法，这些化合物可用作血管紧张素转换酶（ACE）抑制剂和降压剂，并且与另一种降压剂和/或利尿剂化合物结合在一起的药物组合物中含有这些羧基烷基二肽化合物。
• DESIGNER CALVIN-CYCLE-CHANNELED PRODUCTION OF BUTANOL AND RELATED HIGHER ALCOHOLS
  申请人：Lee James Weifu

  公开号：US20110177571A1

  公开（公告）日：2011-07-21

  Designer Calvin-cycle-channeled and photosynthetic NADPH-enhanced pathways, the associated designer genes and designer transgenic photosynthetic organisms for photobiological production of butanol and related higher alcohols from carbon dioxide and water are provided. The butanol and related higher alcohols include 1-butanol, 2-methyl-1-butanol, isobutanol, 3-methyl-1-butanol, 1-hexanol, 1-octanol, 1-pentanol, 1-heptanol, 3-methyl-1-pentanol, 4-methyl-1-hexanol, 5-methyl-1-heptanol, 4-methyl-1-pentanol, 5-methyl-1-hexanol, and 6-methyl-1-heptanol. The designer photosynthetic organisms such as designer transgenic oxyphotobacteria and algae comprise designer Calvin-cycle-channeled and photosynthetic NADPH-enhanced pathway gene(s) and biosafety-guarding technology for enhanced photobiological production of butanol and related higher alcohols from carbon dioxide and water.

  本发明提供了设计师卡尔文循环通道和光合作用NADPH增强途径、相关设计师基因和转基因光合生产丁醇和相关高级醇的生物体，这些生物体利用二氧化碳和水进行光生物生产。所述丁醇和相关高级醇包括1-丁醇、2-甲基-1-丁醇、异丁醇、3-甲基-1-丁醇、1-己醇、1-辛醇、1-戊醇、1-庚醇、3-甲基-1-戊醇、4-甲基-1-己醇、5-甲基-1-庚醇、4-甲基-1-戊醇、5-甲基-1-己醇和6-甲基-1-庚醇。设计师光合生产丁醇和相关高级醇的生物体，例如设计师转基因氧光合细菌和藻类，包括设计师卡尔文循环通道和光合作用NADPH增强途径基因和生物安全防护技术，以增强从二氧化碳和水中光生物生产丁醇和相关高级醇的产量。